Cue Biopharma (CUE) Cash & Current Investments (2017 - 2026)
Cue Biopharma (CUE) recorded Cash & Current Investments of $17.4 million in Q2 2026, down 36.7% from $27.49 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Cash & Current Investments (2017 - 2026) Analysis & Trends
At the end of FY2025, Cue Biopharma reported Cash & Current Investments of $27.14 million, up 20.8% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $22.46 million in FY2024 (-53.7%), $48.51 million in FY2023 (-36.4%), $76.29 million in FY2022 (+18.5%) and $64.37 million in FY2021 (-24.2%).
- The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q1 2025.
- On a year-over-year basis, Cash & Current Investments rose in 1 of the last seven quarters, with an average decline of 32.7%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 20.8% in Q4 2025, against a decline of 68.0% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Cue Biopharma | 117.65 Mn | 26.93 Mn | - | 17.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.40 Mn |
| Dec 31, 2025 | 27.14 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 27.49 Mn |
| Mar 31, 2025 | 13.14 Mn |
| Dec 31, 2024 | 22.46 Mn |
| Sep 30, 2024 | 32.42 Mn |
| Jun 30, 2024 | 30.03 Mn |
| Mar 31, 2024 | 41.03 Mn |
| Dec 31, 2023 | 48.51 Mn |
| Sep 30, 2023 | 54.69 Mn |
| Jun 30, 2023 | 57.89 Mn |
| Mar 31, 2023 | 66.20 Mn |
| Dec 31, 2022 | 76.29 Mn |
| Sep 30, 2022 | 59.18 Mn |
| Jun 30, 2022 | 66.13 Mn |
| Mar 31, 2022 | 67.93 Mn |
| Dec 31, 2021 | 64.37 Mn |
| Sep 30, 2021 | 67.63 Mn |
| Jun 30, 2021 | 73.92 Mn |
API Access
Cue Biopharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();